x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

PETRI DISH PERSPECTIVES

Burma | ChicagoScientist 🥼🧪🔬Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎Stream new episodes every THURSDAY!https://linktr.ee/maneadkhin#biotech #pharma #healthcare #podcast #petridishperspectives

science life sciences

All Episodes

24:43

Episode 18: Gilead Sciences

PETRI DISH PERSPECTIVES ·

2025/08/28

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the remarkable and controversial story of Gilead Sciences, a company that redefined what medicine could achieve. From its beginnings in the late 1980s under physician-scientist Michael Riordan, Gilead transformed antiviral drug development with breakthroughs in HIV treatment, revolutionized global health with a cure for hepatitis C, and pushed into oncology with cutting-edge CAR-T therapies. But alongsi...

en-us

24:22

Episode 17: GSK

PETRI DISH PERSPECTIVES ·

2025/08/21

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the story of GlaxoSmithKline (GSK), one of the world’s most influential pharma giants! From scaling up penicillin production in WWII, to pioneering semi-synthetic antibiotics like amoxicillin, to leading the global vaccine race with Cervarix and Shingrix, GSK has left an indelible mark on modern medicine. We also explore its groundbreaking role in HIV treatment through ViiV Healthcare, and the blockbust...

en-us

26:53

Episode 16: Amgen

PETRI DISH PERSPECTIVES ·

2025/08/14

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive deep into the origin story of Amgen, a company that helped turn “biotechnology” from a niche lab concept into a global medical force. We’ll trace Amgen’s unlikely beginnings in 1980, a time when gene splicing was still the stuff of scientific legend and meet the eclectic founding team: George Rathmann, the charismatic chemist-turned-executive; Winston Salser, the UCLA scientist eager to bring basic research ...

en-us

23:24

Episode 15: BGI Genomics

PETRI DISH PERSPECTIVES ·

2025/08/07

Send us a text What happens when one of the world’s most powerful genomics companies rises from a college dorm in China and goes on to challenge the West’s biotech dominance? In this episode of Petri Dish Perspectives: Biotech Unleashed, we unravel the story of BGI Genomics, a company at the intersection of cutting-edge science, national ambition, and global controversy. From decoding the human genome to building the world’s largest sequencing fleet, BGI’s journey is as bold as it is complex....

en-us

24:55

Episode 14: Abbott

PETRI DISH PERSPECTIVES ·

2025/07/31

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead takes you inside the remarkable story of Abbott Laboratories: a company that doesn’t chase headlines but touches billions of lives every day. From its origins in 1888 as a small Chicago pharmacy mixing precise plant-based pills, Abbott has grown into a global healthcare powerhouse behind life-changing products like the FreeStyle Libre glucose monitor, BinaxNOW COVID-19 tests, Similac baby formula, Ensure...

en-us

23:06

Episode 13: Sarepta Therapeutics

PETRI DISH PERSPECTIVES ·

2025/07/24

Send us a text DISCLAIMER: This is a consistently changing situation. The episode was recorded approximately 4 PM EDT Monday, July 21, 2025. As of 7.40 PM EDT Monday, July 21, 2025 (Source: Sarepta), "Sarepta Therapeutics notified the U.S. FDA of its decision to voluntarily and temporarily pause all shipments of ELEVIDYS (delandistrogene moxeparvovec) for Duchenne muscular dystrophy in the United States, effective close of business Tuesday, July 22, 2025." 🎙️ When Hope Collides with Ris...

en-us

24:55

Episode 12: Vertex

PETRI DISH PERSPECTIVES ·

2025/07/17

Send us a text 🔬✨ From Cystic Fibrosis Breakthroughs to Gene Editing Cures In this episode of Petri Dish Perspectives: Biotech Unleashed, Manead unpacks how Vertex turned cystic fibrosis from a fatal disease into a treatable condition and why they’re now tackling sickle cell, diabetes, and more with CRISPR and stem cell science. Discover how visionary chemists, Nobel-winning gene editors, and patient advocates built one of biotech’s most inspiring success stories, proving that deep science

en-us

26:46

Episode 11: Genentech

PETRI DISH PERSPECTIVES ·

2025/07/10

Send us a text 🧬 From VC to Blockbusters: The Genentech Story In Episode 11 of Petri Dish Perspectives: Biotech Unleashed, host Manead dives into the legendary rise of Genentech, the startup that sparked the biotech revolution. From its humble beginnings in a borrowed lab to pioneering insulin, tPA, Herceptin, and more, learn how Genentech turned recombinant DNA into real-world cures. Discover the bold VC bets, game-changing antibodies, and the Roche acquisition that preserved its

en-us

20:58

Episode 10: Roche

PETRI DISH PERSPECTIVES ·

2025/07/03

Send us a text 💡 From Vitamin C to AI-Driven Diagnostics: Roche’s Legacy Unleashed In this episode of Petri Dish Perspectives: Biotech Unleashed, we explore the extraordinary evolution of Roche, from its origins as a 19th-century Swiss chemical company to becoming a global leader in pharmaceuticals and diagnostics. You’ll hear how Roche launched the world’s first branded vitamin C, pioneered molecular diagnostics with PCR, and laid the groundwork for today’s precision medicine revolution.

en-us

16:01

Episode 9: Bayer

PETRI DISH PERSPECTIVES ·

2025/06/26

Send us a text 🎧 From Dye Pots to Blockbusters: The Bayer Story In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead takes you on a journey through Bayer’s 160+ year evolution, from its 1863 roots in coal tar dyes to becoming the maker of Aspirin 💊, Xarelto ❤️, and Eylea 👁️. We explore how a dye salesman and a master dyer built a pharma empire, the game-changing invention of Aspirin, blockbuster therapies, the turbulent Monsanto acquisition 🌾⚖️, and the company’s

en-us

14:13

Episode 8: Bristol Myers Squibb

PETRI DISH PERSPECTIVES ·

2025/06/19

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we journey through the 165+ year saga of Bristol Myers Squibb (BMS) — from 19th-century Brooklyn apothecaries and sparkling laxatives 💊 to cutting-edge CAR-T therapies and checkpoint inhibitors in cancer treatment 🧫🔥. Host Manead, a PhD scientist in cancer biology and analytical chemistry, breaks down: 📜 The parallel founding stories of E.R. Squibb & Sons and Bristol-Myers 🧠 The game-changing 1989 merger t...

en-us

12:18

Episode 7: Sanofi

PETRI DISH PERSPECTIVES ·

2025/06/12

Send us a text Ever wonder how an oil conglomerate helped create one of the world’s top pharma giants? 💥 In this episode of Petri Dish Perspectives: Biotech Unleashed, your host, Manead, dives into the fascinating story of Sanofi, a company whose name you’ve probably seen on insulin pens 💉, flu shots 🦠, and blockbuster immunology meds 💊. We explore: 🔹 Sanofi’s wild beginnings inside a French oil giant 🛢️ 🔹 Game-changing acquisitions — Aventis, Genzyme, and more 💸 🔹 Lantus an...

en-us

12:48

Episode 6: Merck

PETRI DISH PERSPECTIVES ·

2025/04/30

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we'll take you on a 350-year journey through the rise of Merck — from its humble beginnings as a family-run pharmacy in 17th-century Germany to becoming one of the world’s most influential pharmaceutical powerhouses. We’ll explore how Merck evolved through groundbreaking discoveries like streptomycin, the MMR vaccine, statins, and the game-changing cancer immunotherapy Keytruda. You’ll also hear about the incredible...

en-us

16:11

Episode 5: Boehringer Ingelheim

PETRI DISH PERSPECTIVES ·

2025/04/09

Send us a text 🐴 From Farmyard Roots to Pharma Powerhouse: The Boehringer Ingelheim Story 🐴 Welcome to Petri Dish Perspectives: Biotech Unleashed! 🚀 I’m your host, Manead—scientist and biotech nerd. Today, we’re spotlighting Boehringer Ingelheim—a family-owned pharma giant that began in a small German village and grew into one of the world’s top 20 pharmaceutical companies. From veterinary vaccines to life-saving treatments for respiratory disease, diabetes, and cancer, Boehringer has

en-us

19:35

Episode 4: Johnson & Johnson

PETRI DISH PERSPECTIVES ·

2025/04/02

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the rich history and groundbreaking innovations of Johnson & Johnson (J&J)—one of the most influential healthcare companies in the world. From its origins in the late 19th century as a family-run surgical supply business to becoming a household name with products like Band-Aids, Tylenol, and Johnson’s Baby Powder, J&J has shaped modern medicine in countless ways. We’ll explore how Robert Woo...

en-us

15:40

Episode 3: AbbVie

PETRI DISH PERSPECTIVES ·

2025/03/26

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we explore the rise of AbbVie, a pharmaceutical giant that emerged from Abbott Laboratories in 2013 and quickly became a leader in immunology, oncology, and aesthetics. From its blockbuster drug Humira to major acquisitions like Pharmacyclics and Allergan, AbbVie has strategically expanded its portfolio and global presence. We’ll break down the company’s history, key milestones, and the vision driving its future—inc...

en-us

24:34

Episode 2: Eli Lilly

PETRI DISH PERSPECTIVES ·

2025/03/20

Send us a text Welcome to Petri Dish Perspectives: Biotech Unleashed! In this episode, we dive deep into the history and impact of Eli Lilly, a company that began with a small lab in Indianapolis and has grown into the highest market-cap pharmaceutical company in the world. From pioneering insulin production in the 1920s to developing blockbuster drugs like Prozac, Humalog, and Mounjaro, Eli Lilly has played a crucial role in shaping modern medicine. We’ll explore the founding story, key scie...

en-us

17:17

Episode 1: Pfizer

PETRI DISH PERSPECTIVES ·

2025/03/12

Send us a text 💊 From Brooklyn to Biotech Titan: The Rise of Pfizer 💊 Welcome to the first-ever episode of Petri Dish Perspectives: Biotech Unleashed! 🚀 I’m your host, Manead—scientist, biotech nerd, and your guide through the fascinating world of life sciences. We’re kicking things off with Pfizer—a company that started as a small chemical business in Brooklyn and grew into a global powerhouse. From upscaling penicillin in WWII to revolutionizing cholesterol treatment with Lipitor, turning

en-us

38 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter